CD24 and breast cancer: We have examined the occurrence of SP and the effects of HER2 on SP among receptor-negative BC cell lines (Ba and Bb subtypes) and luminal cell lines (Lu subtype) that were also characterised for ALDH+ and CD44+/CD24− expression.